In their study, two patients (12%) who developed life-threatening COVID-19 despite receiving two or more doses of an inactivated SARS-CoV-2 vaccine were found to have serum autoantibodies that neutralized IFN-α2 and IFN-ω at physiologically relevant concentrations. The gene discussed is IFNA2; the disease is COVID-19.